المؤلفون: Fran Robson, Palma Rocchi, Sinem Demirbag, Thi Khanh Le, Khadija Shahed Khan, Clément Paris, Peter Barfuss, Wai-Lung Ng

المساهمون: University of Bristol [Bristol], The Chinese University of Hong Kong [Hong Kong], Centre de Recherche en Cancérologie de Marseille (CRCM), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU), Hanoi University of Science and Technology (HUST), Sabanci University, Nanotechnology Research and Application Center, Sabanci University [Istanbul], Université Paris-Est (UPE), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Rocchi, Palma

المصدر: Molecular Cell
Molecular Cell, Elsevier, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩
Molecular Cell, 2020, 79 (5), pp.710-727. ⟨10.1016/j.molcel.2020.07.027⟩

مصطلحات موضوعية: antisense oligonucleotide, Transcription, Genetic, MESH: Coronavirus Infections, viruses, [SDV]Life Sciences [q-bio], Cell, coronavirus, Cytidine, Viral Nonstructural Proteins, medicine.disease_cause, Virus Replication, Genome, Severity of Illness Index, 0302 clinical medicine, Transcription (biology), MESH: Molecular Targeted Therapy, MESH: COVID-19, Nucleotide, MESH: Adenosine Monophosphate, Molecular Targeted Therapy, Coronavirus, chemistry.chemical_classification, 0303 health sciences, Alanine, non-structural protein 14, virus diseases, ExoN, MESH: Amides, 3. Good health, [SDV] Life Sciences [q-bio], medicine.anatomical_structure, 030220 oncology & carcinogenesis, MESH: Pyrazines, MESH: RNA, Viral, Pyrazines, Proofreading, MESH: Betacoronavirus, RNA, Viral, MESH: Genome, Viral, Coronavirus Infections, MESH: Cytidine, medicine.drug, MESH: Antiviral Agents, MESH: Pandemics, MESH: Mutation, exonuclease, MESH: Alanine, CoV, Pneumonia, Viral, antisense oligonucleotide (ASO), Computational biology, Genome, Viral, Biology, Therapeutic targeting, Hydroxylamines, Antiviral Agents, Article, ASO, 03 medical and health sciences, Betacoronavirus, MESH: Severity of Illness Index, Coronavirus (CoV), medicine, Humans, MESH: SARS-CoV-2, anti-coronavirus drugs, Molecular Biology, Pandemics, 030304 developmental biology, Exonuclease (ExoN), MESH: Ribonucleosides, MESH: Humans, Nucleoside analogue, SARS-CoV-2, MESH: Transcription, Genetic, MESH: Virus Replication, nucleoside analog, RNA, COVID-19, Correction, MESH: Hydroxylamines, Cell Biology, Amides, Adenosine Monophosphate, non-structural protein 14 (nsp14), respiratory tract diseases, nucleoside analogue (NA), Viral replication, chemistry, MESH: Pneumonia, Viral, Mutation, nsp14, MESH: Viral Nonstructural Proteins, NA, Ribonucleosides, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e7c3d34b3a0e2ab6d0db7eece5c7f1
https://pubmed.ncbi.nlm.nih.gov/33338403

المؤلفون: Marie-Claude Jaurand, Robin Tranchant, Jessica Zucman-Rossi, Clément Meiller, Didier Jean, Lisa Quetel, Julien de Wolf, Leanne de Koning, François Montagne, Françoise Le Pimpec-Barthes

المساهمون: Génomique Fonctionnelle des Tumeurs Solides (U1162), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Labex Immuno-oncology, Université Paris Descartes - Paris 5 (UPD5)-PRES Sorbonne Paris Cité, Institut Universitaire d'Hématologie (IUH), Université Paris Diderot - Paris 7 (UPD7), Université Paris 13 (UP13), Service de Chirurgie Thoracique [CHRU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Lille, Droit et Santé, Laboratoire des biomarqueurs tumoraux circulants [Institut Curie, Paris] (SiRIC - Département de recherche translationnelle), Institut Curie [Paris]-Université Paris sciences et lettres (PSL), Service de Chirurgie Thoracique (Hôpital Européen Georges Pompidou [APHP] HEGP), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Jean, Didier

المصدر: Lung Cancer
Lung Cancer, Elsevier, 2018, 126, pp.15-24. ⟨10.1016/j.lungcan.2018.10.015⟩
Lung Cancer, 2018, 126, pp.15-24. ⟨10.1016/j.lungcan.2018.10.015⟩

مصطلحات موضوعية: 0301 basic medicine, Mesothelioma, MESH: Signal Transduction, Cancer Research, Lung Neoplasms, MESH: Sulfonamides, Apoptosis, Quinolones, [SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, medicine.disease_cause, Target therapy, MESH: Benzamides, 0302 clinical medicine, MESH: Phenols, RNA interference, Tumor Cells, Cultured, Gene knockdown, Sulfonamides, MESH: Gene Expression Regulation, Neoplastic, Verteporfin, 3. Good health, Gene Expression Regulation, Neoplastic, Predictive biomarker, Oncology, MESH: Cell Survival, 030220 oncology & carcinogenesis, Pyrazines, MESH: Pyrazines, Benzamides, [SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], RNA Interference, MESH: Biomarkers, Tumor, Signal transduction, medicine.drug, Signal Transduction, Pulmonary and Respiratory Medicine, Cell Survival, Pleural Neoplasms, MESH: RNA Interference, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, [SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics, MESH: Pleural Neoplasms, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Phenols, MESH: Cell Proliferation, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], medicine, Biomarkers, Tumor, Humans, Viability assay, MESH: Tumor Cells, Cultured, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, Cell Proliferation, Thoracic tumor, Cisplatin, MESH: Humans, MESH: Quinolones, MESH: Mesothelioma, Cell growth, business.industry, MESH: Apoptosis, MESH: Verteporfin, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Tumor molecular classification, MESH: Lung Neoplasms, 030104 developmental biology, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, Cancer research, MESH: Antineoplastic Agents, Signal pathway, Carcinogenesis, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5907b192ad58c6401d8a73ec0a34452
https://www.hal.inserm.fr/inserm-02478609

المؤلفون: Madelain, Vincent, Baize, Sylvain, Jacquot, Frédéric, Reynard, Stéphanie, Fizet, Alexandra, Barron, Stephane, Solas, Caroline, Lacarelle, Bruno, Carbonnelle, Caroline, Mentré, France, Raoul, Hervé, de Lamballerie, Xavier, Guedj, Jérémie

المساهمون: Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biologie des Infections Virales Émergentes - Biology of Emerging Viral Infections (UBIVE), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP), Laboratoire P4 - Jean Mérieux, Centre Européen de Virologie/Immunologie-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Emergence des Pathologies Virales (EPV), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut National de la Santé et de la Recherche Médicale (INSERM), This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 666092, and from the St. Luke’s International University (Tokyo, Japan) in the framework of Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED)., European Project: 666092,H2020,H2020-Adhoc-2014-20,REACTION(2014), Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP), Baize, Sylvain, Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans - REACTION - - H20202014-11-01 - 2016-10-31 - 666092 - VALID, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris]

المصدر: Nature Communications
Nature Communications, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications, Nature Publishing Group, 2018, 9, ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩

مصطلحات موضوعية: MESH: Antiviral Agents, Time Factors, [SDV]Life Sciences [q-bio], Science, viruses, Antiviral Agents, Article, Animals, MESH: Animals, MESH: Ebolavirus, lcsh:Science, MESH: Models, Theoretical, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MESH: Cytokines, MESH: Host-Pathogen Interactions, MESH: Macaca, MESH: Time Factors, Interferon-alpha, Hemorrhagic Fever, Ebola, Models, Theoretical, Viral Load, Ebolavirus, Amides, Survival Analysis, MESH: Amides, Disease Models, Animal, Pyrazines, MESH: Pyrazines, MESH: Survival Analysis, Host-Pathogen Interactions, MESH: Hemorrhagic Fever, Ebola, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Cytokines, Macaca, Female, lcsh:Q, MESH: Disease Models, Animal, MESH: Interferon-alpha, MESH: Viral Load, MESH: Female

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d154ac0e471157d76dc4db477c6eb882
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236192/document

المؤلفون: Pierre Cattan, Julien Castel, Rémy Burcelin, Aurélie Waget, Daniel J. Drucker, Mattieu Armanet, Melis Karaca, Christophe Magnan, Jens J. Holst, Céline Garret, Thierry Sulpice, Gaëlle Payros, Myriam Masseboeuf, Adriano Maida, Cendrine Cabou

المساهمون: Institut des Maladies Métaboliques et Cardiovasculaires ( I2MC ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital de Rangueil, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier ( UPS ), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Cell Therapy Unit, Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ) -Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Biologie Fonctionnelle et Adaptative ( BFA ), Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS ), Department of Medicine, University of Toronto-Samuel Lunenfeld Research Institute-Mount Sinai Hospital ( MSH ), Physiogenex SAS, Prologue Biotech, PHYSIOGENEX S.A.S, Department of Biomedical Sciences, The panum Institute-University of Copenhagen ( KU ), Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Unité de Biologie Fonctionnelle et Adaptative (BFA (UMR_8251 / U1133)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Toronto-Samuel Lunenfeld Research Institute-Mount Sinai Hospital [Toronto, Canada] (MSH), Physiogenex, Department of Biomedical Sciences [Copenhagen], Faculty of Health and Medical Sciences, University of Copenhagen = Københavns Universitet (UCPH)-University of Copenhagen = Københavns Universitet (UCPH), Simon, Marie Francoise, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Toronto-Mount Sinai Hospital [Toronto, Canada] (MSH)-Samuel Lunenfeld Research Institute, University of Copenhagen = Københavns Universitet (KU)-University of Copenhagen = Københavns Universitet (KU)

المصدر: Endocrinology
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. 〈10.1210/en.2011-0286〉
Endocrinology, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩
Endocrinology, Endocrine Society, 2011, 152 (8), pp.3018-29. ⟨10.1210/en.2011-0286⟩

مصطلحات موضوعية: MESH : Insulin, medicine.medical_treatment, MESH : Vagus Nerve, MESH : Receptors, Glucagon, 0302 clinical medicine, Endocrinology, MESH: Dipeptides, MESH: Vagus Nerve, Glucose homeostasis, MESH: Animals, [SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, MESH : Dipeptidyl-Peptidase IV Inhibitors, 0303 health sciences, Glucose tolerance test, MESH: Middle Aged, MESH: Dipeptidyl-Peptidase IV Inhibitors, medicine.diagnostic_test, MESH : Glucagon, MESH: Glucagon, digestive, oral, and skin physiology, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, MESH : Adult, [ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, Glucagon-like peptide-1, 3. Good health, MESH : Pyrazines, MESH: Pyrazines, Sitagliptin, hormones, hormone substitutes, and hormone antagonists, medicine.drug, endocrine system, medicine.medical_specialty, MESH: Glucose Tolerance Test, MESH : Male, MESH : Dipeptides, MESH : Receptors, Gastrointestinal Hormone, Incretin, 030209 endocrinology & metabolism, MESH: Insulin, MESH : Mice, Inbred C57BL, Biology, Sitagliptin Phosphate, MESH : Glucose Tolerance Test, MESH: Receptors, Glucagon, 03 medical and health sciences, MESH: Mice, Inbred C57BL, Internal medicine, MESH : Mice, MESH : Triazoles, medicine, MESH : Middle Aged, MESH: Mice, Dipeptidyl peptidase-4, 030304 developmental biology, MESH: Humans, MESH: Receptors, Gastrointestinal Hormone, Insulin, MESH : Humans, MESH: Adult, MESH: Dipeptidyl Peptidase 4, MESH : Blood Glucose, MESH: Male, MESH: Triazoles, MESH : Dipeptidyl Peptidase 4, MESH: Blood Glucose, MESH : Animals

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f0300570214f5507362f1065f95366
https://doi.org/10.1210/en.2011-0286

المؤلفون: Mathy Froeyen, Leen Delang, Stéphanie Beaucourt, Bruno Canard, Ana Theresa Silveira de Morais, Isabelle Imbert, Johan Neyts, Marco Vignuzzi, Hervé Blanc, Pieter Leyssen, Rana Abdelnabi

المساهمون: Rega Institute for Medical Research [Leuven, België], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Architecture et fonction des macromolécules biologiques (AFMB), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Populations virales et Pathogenèse - Viral Populations and Pathogenesis, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), This work was supported by the BELVIR project from BELSPO (IUAP), the EU-FP7/2011-2014 Project SILVER (GA 260644), and the EU-H2020 Innovative Training Network ANTIVIRALS (GA 642434). A.T.S.D.M. was supported by a postdoctoral fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico—Brasil). L.D. was supported by a postdoctoral fellowship from the FWO (Fund for Scientific Research of Flanders, Belgium)., European Project: 260644,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,SILVER(2010), European Project: 642434,H2020,H2020-MSCA-ITN-2014,ANTIVIRALS(2015), Pfeiffer, Julie K, Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)

المصدر: Journal of Virology
Journal of Virology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩
Journal of Virology, American Society for Microbiology, 2017, 91 (12), pp.e00487-17. ⟨10.1128/JVI.00487-17⟩

مصطلحات موضوعية: 0301 basic medicine, RdRp, viruses, Amino Acid Motifs, Virus Replication, Mice, chemistry.chemical_compound, MESH: Amino Acid Motifs, Japan, MESH: Chlorocebus aethiops, RNA polymerase, Chlorocebus aethiops, MESH: Animals, Polymerase, MESH: Microbial Viability, MESH: Mutagenesis, MESH: Japan, MESH: Drug Resistance, Viral, biology, MESH: Amides, Enterovirus B, Human, 3. Good health, Pyrazines, MESH: Pyrazines, MESH: RNA Replicase, Chikungunya virus, mutagenesis, MESH: Antiviral Agents, MESH: Mutation, Immunology, RNA-dependent RNA polymerase, MESH: Vero Cells, Favipiravir, favipiravir, Antiviral Agents, Microbiology, Virus, 03 medical and health sciences, Virology, Vaccines and Antiviral Agents, Drug Resistance, Viral, Animals, MESH: Lysine, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, CVB3, Vero Cells, MESH: Mice, Microbial Viability, Lysine, MESH: Virus Replication, RNA, MESH: Chikungunya virus, [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology, Processivity, RNA-Dependent RNA Polymerase, Amides, 030104 developmental biology, fidelity, chemistry, Viral replication, MESH: Enterovirus B, Human, Insect Science, Mutation, biology.protein

وصف الملف: Electronic-Print

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ec8ca79e6936169943b98e6fae68ff
https://hal-pasteur.archives-ouvertes.fr/pasteur-02545928

المؤلفون: Nguyen, Thi Huyen Tram, Guedj, Jérémie, Anglaret, Xavier, Laouénan, Cédric, Madelain, Vincent, Taburet, Anne-Marie, Baize, Sylvain, Sissoko, Daouda, Pastorino, Boris, Rodallec, Anne, Piorkowski, Géraldine, Carazo, Sara, Conde, Mamoudou N, Gala, Jean-Luc, Bore, Joseph Akoi, Carbonnelle, Caroline, Jacquot, Frédéric, Raoul, Hervé, Malvy, Denis, de Lamballerie, Xavier, Mentré, France, JIKI study group

المساهمون: Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Programme PAC-CI, ANRS France Recherche Nord & sud Sida-hiv hépatites, Laboratoire de Biotechnologie et Microbiologie Appliquée (LBMA), Institut National de la Recherche Agronomique (INRA)-Université Bordeaux Segalen - Bordeaux 2, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Biologie des Infections Virales Émergentes - Biology of Emerging Viral Infections (UBIVE), Centre International de Recherche en Infectiologie - UMR (CIRI), Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], Emergence des Pathologies Virales (EPV), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU), Médecins Sans Frontières Belgique, The Alliance for International Medical Action [Dakar, Sénégal] (ONG ALIMA), Université Catholique de Louvain = Catholic University of Louvain (UCL), Laboratoire des Fièvres Hémorragiques en Guinée, Université Gamal Abdel Nasser de Conakry, Laboratoire P4 - Jean Mérieux, Centre Européen de Virologie/Immunologie-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM), The JIKI trial was supported by grants from the French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France, http://www.anrs.fr/), the French Institute for Health Research (Inserm, Paris, France, http://www.inserm.fr/) and the European Commission (EU Horizon 2020 programme, grant N° 666092 - REACTION, http://ec.europa.eu/programmes/horizon2020/)., European Project: 666092,H2020,H2020-Adhoc-2014-20,REACTION(2014), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Bordeaux Segalen - Bordeaux 2-Institut National de la Recherche Agronomique (INRA), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris], MATEO, MATHIEU, Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans - REACTION - - H20202014-11-01 - 2016-10-31 - 666092 - VALID, Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris] (IP), UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique), UCL - (SLuc) Centre de génétique médicale UCL, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM), Université Catholique de Louvain (UCL)

المصدر: PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol 11, Iss 2, p e0005389 (2017)
PLOS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2017, 11 (2), pp.e0005389. ⟨10.1371/journal.pntd.0005389⟩
PLoS Neglected Tropical Diseases, Vol. 11, no.2, p. e0005389 [1-18] (2017)

مصطلحات موضوعية: Male, Physiology, Blood plasma, Biochemistry, MESH: Child, Medicine and Health Sciences, Viral load, Child, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MESH: Aged, MESH: Guinea, MESH: Middle Aged, Pharmaceutics, lcsh:Public aspects of medicine, Hematology, Middle Aged, Ebolavirus, MESH: Amides, Body Fluids, Blood, MESH: Young Adult, Child, Preschool, Pyrazines, Creatinine, MESH: Pyrazines, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Female, Drug therapy, Anatomy, Research Article, Adult, MESH: Antiviral Agents, lcsh:Arctic medicine. Tropical medicine, Adolescent, lcsh:RC955-962, Antiviral Agents, Microbiology, Young Adult, Virology, Albumins, Dose prediction methods, Humans, Pharmacokinetics, MESH: Ebolavirus, Aged, Pharmacology, MESH: Adolescent, MESH: Humans, MESH: Child, Preschool, Biology and Life Sciences, Proteins, lcsh:RA1-1270, MESH: Adult, Hemorrhagic Fever, Ebola, Amides, MESH: Male, MESH: Hemorrhagic Fever, Ebola, Guinea, MESH: Female, Biomarkers, Viral Transmission and Infection

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1051530eae51cb41207f0c146dd54e76
https://hal.archives-ouvertes.fr/hal-02309055

المؤلفون: Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll, Matthew L Albert

المساهمون: Immunobiologie des Cellules Dendritiques, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Histopathologie humaine et Modèles animaux, Institut Pasteur [Paris] (IP), Funding was provided by the Institut Pasteur (Pasteur-Roux post-doctoral fellowship to R.B.d.S.), the Pasteur Foundation (fellowship to M.E.L.), the Ligue Contre le Cancer (M.L.A.), the Fondation ARC pour la recherche sur le cancer (M.L.A.) and the French government's Invest in the Future Program, managed by the Agence Nationale de la Recherche (LabEx Immuno-Onco (R.B.d.S., M.E.L., N.Y., M.A.I. and M.L.A.))., ANR-11-IDEX-0005,USPC,Université Sorbonne Paris Cité(2011), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris]

المصدر: Nature Immunology
Nature Immunology, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩
Nature Immunology, Nature Publishing Group, 2015, 16 (8), pp.850-858. ⟨10.1038/ni.3201⟩

مصطلحات موضوعية: Male, Adoptive cell transfer, Lymphocyte, medicine.medical_treatment, Cancer immunotherapy, MESH: Flow Cytometry, CXCR3, MESH: Mice, Knockout, MESH: Cell Movement/drug effects, 0302 clinical medicine, Cell Movement, MESH: Triazoles/pharmacology, Immunology and Allergy, MESH: Animals, MESH: Chemokines/metabolism, Lymphocytes, Mice, Knockout, Mice, Inbred BALB C, 0303 health sciences, Chemistry, Flow Cytometry, Adoptive Transfer, 3. Good health, MESH: Dipeptidyl Peptidase 4/immunology, medicine.anatomical_structure, MESH: Neoplasms, Experimental/genetics, MESH: Dipeptidyl Peptidase 4/genetics, MESH: Pyrazines/pharmacology, Pyrazines, 030220 oncology & carcinogenesis, MESH: Neoplasms, Experimental/immunology, MESH: Chemokine CXCL10/metabolism, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Immunotherapy, Chemokines, MESH: Chemokine CXCL10/immunology, Receptors, CXCR3, MESH: Cell Line, Tumor, MESH: Mice, Transgenic, Dipeptidyl Peptidase 4, T cell, Immunology, MESH: Mice, Inbred BALB C, MESH: Immunotherapy/methods, MESH: Cell Movement/immunology, Mice, Transgenic, MESH: Receptors, CXCR3/immunology, 03 medical and health sciences, Immune system, MESH: Mice, Inbred C57BL, Cell Line, Tumor, MESH: Lymphocytes/metabolism, medicine, Animals, CXCL10, MESH: Sitagliptin Phosphate, 030304 developmental biology, MESH: Neoplasms, Experimental/therapy, Dipeptidyl-Peptidase IV Inhibitors, Protein transport, MESH: Dipeptidyl-Peptidase IV Inhibitors/pharmacology, Sitagliptin Phosphate, Neoplasms, Experimental, Triazoles, MESH: Male, Chemokine CXCL10, Mice, Inbred C57BL, MESH: Adoptive Transfer, MESH: Receptors, CXCR3/metabolism, MESH: Dipeptidyl Peptidase 4/metabolism, MESH: Lymphocytes/immunology, MESH: Female, MESH: Chemokines/immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e2ab8828a29afd88e17c54fdc280cd
https://hal-pasteur.archives-ouvertes.fr/pasteur-01380810

المؤلفون: Odile Burlet-Schiltz, Bernard Monsarrat, Stéphane Manenti, Marie-Pierre Bousquet-Dubouch, Mariette Matondo, Christian Recher, Sandrine Uttenweiler-Joseph, Bernard Payrastre, Nathalie Gallay

المساهمون: Institut de pharmacologie et de biologie structurale (IPBS), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Centre de Physiopathologie de Toulouse-Purpan (INSERM U563 - CNRS UMR1037), Centre National de la Recherche Scientifique (CNRS)-Centre de lutte contre le cancer (CLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Institut Claudius Regaud, This work was supported by the CNRS, by grants from the Fonds Sociaux Européens and the Ligue contre le Cancer (MM), and in part by grants from the Région Midi-Pyrénées and the Génopole Toulouse Midi-Pyrénées., The authors would like to thank Millennium Pharmaceuticals for their generous gift of bortezomib and are very grateful to Dr. C. Demur for helpful assistance in managing the patient samples used in this study.

المصدر: Leukemia Research
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩

مصطلحات موضوعية: Proteomics, Male, Cancer Research, Leupeptins, MESH: Drug Resistance, Neoplasm / drug effects, MESH: Leukemia, Myeloid, Acute / metabolism, Apoptosis, MESH: Proteasome Endopeptidase Complex / metabolism, Proteasome regulators, Bortezomib, MESH: Aged, 80 and over, 0302 clinical medicine, Tumor Cells, Cultured, MESH: Bortezomib, MESH: Aged, Aged, 80 and over, MESH: Proteasome Endopeptidase Complex / analysis, 0303 health sciences, MESH: Middle Aged, MESH: Leukemia, Myeloid, Acute / pathology, U937 cell, Myeloid leukemia, U937 Cells, Hematology, Middle Aged, Cell cycle, Prognosis, Boronic Acids, 3. Good health, Leukemia, Myeloid, Acute, Oncology, Pyrazines, 030220 oncology & carcinogenesis, MESH: Pyrazines / pharmacology, Female, MESH: Daunorubicin / pharmacology, Proteasome Inhibitors, medicine.drug, Adult, Proteasome Endopeptidase Complex, MESH: Protease Inhibitors / pharmacology, Daunorubicin, Antineoplastic Agents, HL-60 Cells, MESH: U937 Cells, Biology, MESH: Prognosis, 03 medical and health sciences, MESH: Leukemia, Myeloid, Acute / diagnosis, MESH: Proteasome Inhibitors, MESH: Apoptosis / drug effects, MESH: HL-60 Cells, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Protease Inhibitors, MESH: Tumor Cells, Cultured, Aged, 030304 developmental biology, MESH: Humans, Mass spectrometry, MESH: Drug Resistance, Neoplasm / physiology, MESH: Leupeptins / pharmacology, MESH: Adult, MESH: Boronic Acids / pharmacology, 2D gel electrophoresis, MESH: Antineoplastic Agents / pharmacology, MESH: Male, 20S proteasome, Proteasome, Drug Resistance, Neoplasm, Proteasome inhibitor, Cancer research, MESH: Female

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c9c627ffc922f7fa4dfe1b585c758e
https://doi.org/10.1016/j.leukres.2009.09.020

المؤلفون: Patrick Lacolley, Mickael Lhuillier, Pierre Y. Marie, Huguette Louis, S. Poussier, Henri Boutley, Gilles Karcher, Simon N. Thornton, Fatiha Maskali

المساهمون: Nancyclotep- Experimental Imaging Platform = Plate-forme d'imagerie moléculaire, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Université de Lorraine (UL), Faculté de Médecine [Nancy], Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)

المصدر: International Journal of Cardiovascular Imaging
International Journal of Cardiovascular Imaging, Springer Verlag, 2014, 30 (2), pp.449-456. ⟨10.1007/s10554-013-0350-3⟩

مصطلحات موضوعية: Male, Cardiac Catheterization, Time Factors, Cardiac fibrosis, medicine.medical_treatment, MESH: Rats, Inbred SHR, Rats, Inbred WKY, MESH: Stroke Volume, Ventricular Function, Left, MESH: Ventricular Function, Left, MESH: Hypertension, MESH: Fluorodeoxyglucose F18, Rats, Inbred SHR, MESH: Animals, Cardiac imaging, Cardiac catheterization, MESH: Lipid Metabolism, Ejection fraction, Ventricular Remodeling, MESH: Cardiac Catheterization, Stroke volume, MESH: Positron-Emission Tomography, MESH: Predictive Value of Tests, Pyrazines, MESH: Pyrazines, Hypertension, MESH: Fibrosis, Cardiology, cardiovascular system, Radiographic Image Interpretation, Computer-Assisted, Cardiology and Cardiovascular Medicine, MESH: Radiopharmaceuticals, MESH: Rats, Inbred WKY, medicine.medical_specialty, MESH: Rats, Heart Ventricles, MESH: Arterial Pressure, MESH: Ventricular Remodeling, MESH: Imaging, Three-Dimensional, Imaging, Three-Dimensional, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Fluorodeoxyglucose F18, Predictive Value of Tests, Internal medicine, medicine, MESH: Radiographic Image Interpretation, Computer-Assisted, Animals, Arterial Pressure, Radiology, Nuclear Medicine and imaging, Ventricular remodeling, Heart Failure, business.industry, MESH: Time Factors, Stroke Volume, Lipid Metabolism, medicine.disease, Fibrosis, MESH: Male, Rats, Disease Models, Animal, Blood pressure, Endocrinology, Positron-Emission Tomography, Heart failure, MESH: Heart Failure, MESH: Heart Ventricles, Radiopharmaceuticals, MESH: Disease Models, Animal, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13697aab31f0593efed158ce3435657f
https://hal.univ-lorraine.fr/hal-01738436

المؤلفون: A. El Yamani, Roch Houot, J L Harousseau, Kamal Bouabdallah, Stéphane Courby, M. Ojeda Uribe, Nina Arakelyan, M. Alexis Vigier, Hervé Maisonneuve, Philippe Rodon, Caroline Dartigeas, S. Le Gouill, Remy Gressin, O. Tournilhac, Marie-Pierre Moles, Laurent Sutton, Luc Mathieu Fornecker, D. Assouline, Sylvie Caulet-Maugendre, Christiane Mounier

المساهمون: Microenvironnement et cancer (MiCa), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), Service d'hématologie clinique, Hôpital Hôtel-Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hematology, Centre Hospitalier Emile Muller [Mulhouse] (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA)-Groupe Hospitalier de Territoire Haute Alsace (GHTHA), Department of clinical hematology, CHU Grenoble, Nutrition, croissance et cancer (U 1069) (N2C), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), PRES Université Nantes Angers Le Mans (UNAM), Clinical Haematology, CHU Hôtel-Dieu, Service d'hématologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre hospitalier du Mans, Centre Hospitalier Le Mans (CH Le Mans), Service greffe de moelle osseuse, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'hématologie [Hôpital Edouard Herriot - HCL], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre hospitalier La Roche-Sur-Yon, Université de Rennes (UR)-Hôpital Pontchaillou, Signalisation et Réponses aux Agents Infectieux et Chimiques (SeRAIC), Université de Rennes (UR), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Centre de Recherche en Cancérologie / Nantes - Angers (CRCNA), Centre hospitalier universitaire de Nantes (CHU Nantes)-Faculté de Médecine d'Angers-Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Centre National de la Recherche Scientifique (CNRS)-Hôpital Laennec-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôtel-Dieu de Nantes, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Tours, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-IFR140

المصدر: Annals of Oncology
Annals of Oncology, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Elsevier, 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩
Annals of Oncology, Oxford University Press (OUP), 2012, 23 (6), pp.1555-61. ⟨10.1093/annonc/mdr450⟩

مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, Kaplan-Meier Estimate, Lymphoma, Mantle-Cell, Dexamethasone, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, rituximab, MESH: Aged, 80 and over, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, 0303 health sciences, Bortezomib, bortezomib, Hematology, MESH: Chlorambucil, Boronic Acids, Chemotherapy regimen, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Treatment Outcome, Pyrazines, 030220 oncology & carcinogenesis, MESH: Pyrazines, MESH: Dexamethasone, Female, Rituximab, MESH: Boronic Acids, medicine.drug, medicine.medical_specialty, Vincristine, lymphoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, elderly, Disease-Free Survival, 03 medical and health sciences, MESH: Doxorubicin, Internal medicine, medicine, Humans, MESH: Kaplan-Meier Estimate, Aged, 030304 developmental biology, mantle cell, Chemotherapy, MESH: Humans, Chlorambucil, business.industry, medicine.disease, MESH: Male, Surgery, Regimen, Doxorubicin, MESH: Antibodies, Monoclonal, Murine-Derived, MESH: Disease-Free Survival, Mantle cell lymphoma, MESH: Lymphoma, Mantle-Cell, business, MESH: Female

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80680ac9758f397fa5d55a714413ee05
https://hal.science/hal-00744066